AI has become a critical tool in diagnosing and managing viral infections such as influenza, respiratory syncytial virus (RSV ...

WHAT WE FOUND Human Metapneumovirus (HMPV) is not new. The respiratory virus was first identified in 2001, according to the Centers for Disease Control and Prevention.

Sanofi SA (NASDAQ:SNY) on Tuesday agreed to acquire Vicebio Ltd, a privately held biotechnology company headquartered in ...

The acquisition, which will give Sanofi a combination vaccine for respiratory syncytial virus and human metapneumovirus, ...

In China, HMPV ranked eighth among the eight viruses that cause acute respiratory infections, with a positive rate of 4.1 percent, which is far lower than the 28.5 percent rate of the influenza virus.

Two recent studies published this week assess the low uptake of respiratory syncytial virus (RSV) vaccine among US veterans ...

The deal adds vaccine candidates for respiratory syncytial virus and human metapneumovirus to the French pharmaceutical group ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

The human metapneumovirus (hMPV) is not new in China or elsewhere in the world, its recent spike in China is within the usual range for winter and there is no evidence that China has declared a ...

4. Melgar M, Britton A, Roper LE, et al. Use of respiratory syncytial virus vaccines in older adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.